Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Sanara MedTech (SMTI) Interest Expenses (2016 - 2025)

Sanara MedTech's Interest Expenses history spans 15 years, with the latest figure at $1.8 million for Q4 2025.

  • For Q4 2025, Interest Expenses rose 42.19% year-over-year to $1.8 million; the TTM value through Dec 2025 reached $6.8 million, up 116.08%, while the annual FY2025 figure was $6.8 million, 116.08% up from the prior year.
  • Interest Expenses reached $1.8 million in Q4 2025 per SMTI's latest filing, up from $1.8 million in the prior quarter.
  • In the past five years, Interest Expenses ranged from a high of $1.8 million in Q4 2025 to a low of $6.0 in Q1 2023.
  • Average Interest Expenses over 5 years is $709962.3, with a median of $287483.0 recorded in 2023.
  • Peak YoY movement for Interest Expenses: plummeted 91.49% in 2021, then skyrocketed 4455500.0% in 2024.
  • A 5-year view of Interest Expenses shows it stood at $711.0 in 2021, then soared by 15600.42% to $111630.0 in 2022, then soared by 157.53% to $287483.0 in 2023, then soared by 348.42% to $1.3 million in 2024, then skyrocketed by 42.19% to $1.8 million in 2025.
  • Per Business Quant, the three most recent readings for SMTI's Interest Expenses are $1.8 million (Q4 2025), $1.8 million (Q3 2025), and $1.8 million (Q2 2025).